# Failure Rate of GLyburide And Metformin Among Gestational Diabetics

> **NCT03078725** · PHASE4 · WITHDRAWN · sponsor: **The University of Texas Health Science Center, Houston**

## Conditions studied

- Gestational Diabetes Mellitus, Class A2

## Interventions

- **DRUG:** Glyburide
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT03078725
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-06-20
- **Primary completion:** 2018-03-10
- **Final completion:** 2018-05-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Research was competing with other projects in the department, and no patients were recruited.
- **Last updated:** 2018-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03078725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03078725, "Failure Rate of GLyburide And Metformin Among Gestational Diabetics". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03078725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*